Pfizer And Auxilium Set Partnership For European Rights To Xiaflex
This article was originally published in The Pink Sheet Daily
Executive Summary
For $75 million upfront plus milestones and royalties, Pfizer gets Xiaflex rights for two indications in 46 countries.
You may also be interested in...
Financings Of The Fortnight: IPOs Make A Return In Talecris And Omeros Deals
Money continued to flow to big and small biotechs, including nearly a dozen PIPEs or registered direct offerings.
Financings Of The Fortnight: IPOs Make A Return In Talecris And Omeros Deals
Money continued to flow to big and small biotechs, including nearly a dozen PIPEs or registered direct offerings.
Auxilium Xiaflex's Advisory Committee To Focus On Physician Expertise, Training
Majority of clinical trial investigators were hand or orthopedic surgeons and FDA asks if this level of expertise is needed to safely use the biologic.